Soluble RAGE further stratifies risk of coronary artery and end-stage kidney disease in high-risk individuals with type 1 diabetes and treatment-resistant hypertension

Abstract Background Soluble receptor for advanced glycation end-products (sRAGE) modulates RAGE-mediated inflammation and oxidative stress. We investigated if sRAGE stratifies cardiovascular and kidney disease risk in individuals with type 1 diabetes and baseline treatment-resistant hypertension (TR...

Descrición completa

Detalles Bibliográficos

Principais autores:	Krishna Adeshara, Raija Lithovius, Stefan Mutter, Valma Harjutsalo, Markku Lehto, Per-Henrik Groop, Niina Sandholm, the FinnDiane Study Group
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2025-12-01
Series:	Cardiovascular Diabetology
Assuntos:	Soluble RAGE Treatment-resistant hypertension Coronary artery disease Kidney disease Type 1 diabetes
Acceso en liña:	https://doi.org/10.1186/s12933-025-03017-8
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!